CHAD D. EHRENKRANZ is an elite healthcare regulatory and transactional lawyer who represents private equity sponsors, their portfolio companies, strategic investors, founders, and providers within the healthcare sector. Chad was recognized in Chambers USA (2020–2024) for his transactional work in Healthcare in New York, where clients commented, “[Chad] is very intellectually sharp; in really complex issues, he drills down to the problem.” In the 2022 edition, clients also noted that “Chad is fabulous. He is extremely knowledgeable, knows the industry and is always there to help.” His commercial approach, innovative structural solutions (e.g., led the healthcare regulatory aspects and design of complex and novel liability management exercises for organizations such as Envision Healthcare), and significant career deal volume, including high caliber repetitions across the healthcare spectrum, uniquely position him to move the needle as few others can. As a result, Chad is regularly called upon as special regulatory counsel in connection with major acquisitions, dispositions, and regulatory matters on behalf of healthcare strategic investors, public companies, private equity sponsors, and their platforms/portfolio companies. Chad has also been honored as a 2021 “Healthcare Trailblazer” by The National Law Journal, among other notable recognitions.
Chad provides business-critical legal, transactional, and regulatory counsel to both lenders and public and private borrowers in the healthcare and life sciences sectors as well as hospitals, healthcare management companies, ambulatory surgery centers, anesthesia providers, long-term acute care hospitals, urgent care centers, veterinary platforms, behavioral health platforms, hyperbaric and wound care management platforms, value-based care platforms, freestanding emergency rooms, diagnostic imaging facilities, skilled nursing facilities, home health agencies, assisted living facilities, durable medical equipment companies, medical supply companies, insurance companies, physician practices, and dentists. Chad also has deep experience providing strategic counsel to clients in transactions involving a wide range of digital health companies, including telemedicine, electronic health record (EHR), revenue cycle management (RCM), artificial intelligence (AI), remote physiologic monitoring (RPM), remote therapeutic monitoring (RTM), patient scheduling, and mobile health (mHealth) companies.
Chad regularly counsels clients on the corporate practice of medicine and licensed professionals, state, and federal fraud and abuse laws, which include but are not limited to, Stark Law, Anti-Kickback Statute, False Claims Act, EKRA, HIPAA, state anti-referral and anti-kickback laws, and related regulatory issues. Chad is experienced in federal and state healthcare regulatory and licensure, enrollment, and reimbursement matters.
Through his extensive regulatory and transactional work (primary platform and add-on acquisitions) Chad has become the go-to lawyer in numerous healthcare spaces as further described on a representative sample of matters set forth on his deal sheet. Chad acts as outside healthcare general counsel for several clients.
Prior to joining Sidley in April 2023, Chad was a founding partner of the Healthcare group for a Top 10 AM Law 100 global law firm, where he led the healthcare team on approximately 1,000 healthcare transactions and regulatory matters.